These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27514496)

  • 1. Elucidating the anti-Staphylococcus aureus antibody response by immunoproteomics.
    Stentzel S; Gläser R; Bröker BM
    Proteomics Clin Appl; 2016 Oct; 10(9-10):1011-1019. PubMed ID: 27514496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune proteomics of Staphylococcus aureus.
    Bröker BM; van Belkum A
    Proteomics; 2011 Aug; 11(15):3221-31. PubMed ID: 21710570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG4 subclass-specific responses to Staphylococcus aureus antigens shed new light on host-pathogen interaction.
    Swierstra J; Debets S; de Vogel C; Lemmens-den Toom N; Verkaik N; Ramdani-Bouguessa N; Jonkman MF; van Dijl JM; Fahal A; van Belkum A; van Wamel W
    Infect Immun; 2015 Feb; 83(2):492-501. PubMed ID: 25404029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray-based identification of human antibodies against Staphylococcus aureus antigens.
    Kloppot P; Selle M; Kohler C; Stentzel S; Fuchs S; Liebscher V; Müller E; Kale D; Ohlsen K; Bröker BM; Zipfel PF; Kahl BC; Ehricht R; Hecker M; Engelmann S
    Proteomics Clin Appl; 2015 Dec; 9(11-12):1003-11. PubMed ID: 25676254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comprehensive View on the Human Antibody Repertoire Against
    Meyer TC; Michalik S; Holtfreter S; Weiss S; Friedrich N; Völzke H; Kocher T; Kohler C; Schmidt F; Bröker BM; Völker U
    Front Immunol; 2021; 12():651619. PubMed ID: 33777051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoproteomics: the key to discovery of new vaccine antigens against bacterial respiratory infections.
    Dennehy R; McClean S
    Curr Protein Pept Sci; 2012 Dec; 13(8):807-15. PubMed ID: 23305366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered immune proteome of Staphylococcus aureus under iron-restricted growth conditions.
    Stentzel S; Vu HC; Weyrich AM; Jehmlich N; Schmidt F; Salazar MG; Steil L; Völker U; Bröker BM
    Proteomics; 2014 Aug; 14(16):1857-67. PubMed ID: 24888718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Diagnostic Serum Antibody Test for Patients With Staphylococcus aureus Osteomyelitis.
    Nishitani K; Beck CA; Rosenberg AF; Kates SL; Schwarz EM; Daiss JL
    Clin Orthop Relat Res; 2015 Sep; 473(9):2735-49. PubMed ID: 26013151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards the immune proteome of Staphylococcus aureus - The anti-S. aureus antibody response.
    Holtfreter S; Kolata J; Bröker BM
    Int J Med Microbiol; 2010 Feb; 300(2-3):176-92. PubMed ID: 19889576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune control of Staphylococcus aureus - regulation and counter-regulation of the adaptive immune response.
    Bröker BM; Holtfreter S; Bekeredjian-Ding I
    Int J Med Microbiol; 2014 Mar; 304(2):204-14. PubMed ID: 24462009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory Mice Are Frequently Colonized with
    Schulz D; Grumann D; Trübe P; Pritchett-Corning K; Johnson S; Reppschläger K; Gumz J; Sundaramoorthy N; Michalik S; Berg S; van den Brandt J; Fister R; Monecke S; Uy B; Schmidt F; Bröker BM; Wiles S; Holtfreter S
    Front Cell Infect Microbiol; 2017; 7():152. PubMed ID: 28512627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global antibody response to Staphylococcus aureus live-cell vaccination.
    Selle M; Hertlein T; Oesterreich B; Klemm T; Kloppot P; Müller E; Ehricht R; Stentzel S; Bröker BM; Engelmann S; Ohlsen K
    Sci Rep; 2016 Apr; 6():24754. PubMed ID: 27103319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population variation in anti-S. aureus IgG isotypes influences surface protein A mediated immune subversion.
    Whitehouse J; Flaxman A; Rollier C; O'Shea MK; Fallowfield J; Lindsay M; Gunner F; Knox K; Wyllie DH; Yamaguchi Y
    Vaccine; 2016 Apr; 34(15):1792-9. PubMed ID: 26921780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic Identification of saeRS-Dependent Targets Critical for Protective Humoral Immunity against Staphylococcus aureus Skin Infection.
    Zhao F; Cheng BL; Boyle-Vavra S; Alegre ML; Daum RS; Chong AS; Montgomery CP
    Infect Immun; 2015 Sep; 83(9):3712-21. PubMed ID: 26169277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of adjuvants on the immune response of sheep to a novel Staphylococcus aureus vaccine.
    Watson DL; Davies HI
    Vet Microbiol; 1993 Feb; 34(2):139-53. PubMed ID: 8451830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human and Staphylococcus aureus proteins in respiratory mucosa by in vivo- and immunoproteomics.
    Schmidt F; Meyer T; Sundaramoorthy N; Michalik S; Surmann K; Depke M; Dhople V; Gesell Salazar M; Holtappels G; Zhang N; Bröker BM; Bachert C; Völker U
    J Proteomics; 2017 Feb; 155():31-39. PubMed ID: 28099884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with Staphylococcus aureus lysate incorporated into microspheres.
    O'Brien CN; Guidry AJ; Douglass LW; Westhoff DC
    J Dairy Sci; 2001 Aug; 84(8):1791-9. PubMed ID: 11518302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The staphylococcal surface-glycopolymer wall teichoic acid (WTA) is crucial for complement activation and immunological defense against Staphylococcus aureus infection.
    Kurokawa K; Takahashi K; Lee BL
    Immunobiology; 2016 Oct; 221(10):1091-101. PubMed ID: 27424796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage.
    Clarke SR; Brummell KJ; Horsburgh MJ; McDowell PW; Mohamad SA; Stapleton MR; Acevedo J; Read RC; Day NP; Peacock SJ; Mond JJ; Kokai-Kun JF; Foster SJ
    J Infect Dis; 2006 Apr; 193(8):1098-108. PubMed ID: 16544250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study.
    Frenck RW; Creech CB; Sheldon EA; Seiden DJ; Kankam MK; Baber J; Zito E; Hubler R; Eiden J; Severs JM; Sebastian S; Nanra J; Jansen KU; Gruber WC; Anderson AS; Girgenti D
    Vaccine; 2017 Jan; 35(2):375-384. PubMed ID: 27916408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.